Powder: -20°C for 3 years
In solvent: -80°C for 2 years
When compared to other Caspase inhibitors, Z-DRHD-FMK inhibited Caspase 6 activity more effectively than the general Caspase inhibitor of Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the Caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone. However, it was less effective in inhibiting TNFα-induced Apoptosis than Z-VAD-FMK or Z-VEID-FMK, presumably.
Description | When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor of Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone. However, it was less effective in inhibiting TNFα-induced apoptosis than Z-VAD-FMK or Z-VEID-FMK, presumably. |
In vitro | The caspase-6-specific inhibitor Z-VEID- FMK and general caspase inhibitors significantly prevent apoptosis of caspase-6-microinjected neurons2. Z-VEID-FMK, which inhibits caspase-6, was also able to abolish the cleavage of procaspase-8, although caspase-6 is activated downstream of caspase-8 in Fas-mediated apoptosis3. |
Molecular Weight | 652.71 |
Formula | C31H45FN4O10 |
CAS No. | T23555 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: ≥113.4mg/mL
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Z-VEID-FMK T23555 Others Z VEID FMK ZVEIDFMK Inhibitor inhibitor inhibit